Form 8.3

Summary by AI BETAClose X

Qube Research & Technologies Limited disclosed an opening position in Advanced Medical Solutions Group plc on 05-11-2026 showing zero direct holdings but cash-settled derivative exposure of 8,038,257 shares, representing 3.63% of the 5p ordinary share capital; there are no stock-settled derivatives or short positions, no voting or acquisition arrangements, and no Supplemental Form 8 attached; disclosed equity swap dealings on 05-11-2026 increased a long position by 12,308 units at 283.00p and 2,780 units at 283.50p; disclosure date 06-11-2026.

Disclaimer*

UK 100

Latest directors dealings